SI1240905T1 - Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids - Google Patents

Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids

Info

Publication number
SI1240905T1
SI1240905T1 SI9730706T SI9730706T SI1240905T1 SI 1240905 T1 SI1240905 T1 SI 1240905T1 SI 9730706 T SI9730706 T SI 9730706T SI 9730706 T SI9730706 T SI 9730706T SI 1240905 T1 SI1240905 T1 SI 1240905T1
Authority
SI
Slovenia
Prior art keywords
toxoids
diphtheriae
tetanus
pertussis vaccine
acellular pertussis
Prior art date
Application number
SI9730706T
Other languages
English (en)
Slovenian (sl)
Inventor
Patrick Florent
Jean Stephenne
Christian Vandecasserie
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of SI1240905T1 publication Critical patent/SI1240905T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0016Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/10Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SI9730706T 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids SI1240905T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9623233.5A GB9623233D0 (en) 1996-11-07 1996-11-07 Vaccine composition

Publications (1)

Publication Number Publication Date
SI1240905T1 true SI1240905T1 (en) 2005-10-31

Family

ID=10802615

Family Applications (2)

Application Number Title Priority Date Filing Date
SI9730394T SI0941117T1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids
SI9730706T SI1240905T1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI9730394T SI0941117T1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids

Country Status (30)

Country Link
EP (2) EP1240905B3 (da)
JP (1) JP3980652B2 (da)
KR (1) KR100518044B1 (da)
CN (1) CN1130226C (da)
AR (1) AR011509A1 (da)
AT (2) ATE295178T1 (da)
AU (1) AU710475B2 (da)
BR (2) BR9712917A (da)
CA (1) CA2271008C (da)
CO (1) CO4910171A1 (da)
CY (2) CY2407B1 (da)
CZ (1) CZ295954B6 (da)
DE (3) DE69715031T2 (da)
DK (2) DK1240905T5 (da)
ES (2) ES2182131T3 (da)
GB (1) GB9623233D0 (da)
HK (2) HK1050473B (da)
HU (1) HU224126B1 (da)
IL (1) IL129530A (da)
LU (1) LU91183I2 (da)
NO (2) NO320186B1 (da)
NZ (1) NZ335384A (da)
PL (1) PL188460B1 (da)
PT (2) PT1240905E (da)
SA (1) SA98181128B1 (da)
SI (2) SI0941117T1 (da)
TR (1) TR199900979T2 (da)
TW (1) TW471971B (da)
WO (1) WO1998019702A1 (da)
ZA (1) ZA979984B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004314A1 (fr) * 1998-11-26 2000-05-31 Pasteur Merieux MSD Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée
KR100374813B1 (ko) * 2000-04-07 2003-03-03 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP5007425B2 (ja) * 2006-01-30 2012-08-22 財団法人ヒューマンサイエンス振興財団 百日咳ワクチンの安全性評価方法
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
DK2459216T3 (da) 2009-09-02 2013-12-09 Novartis Ag Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer
CN105999275A (zh) 2010-09-01 2016-10-12 诺华有限公司 免疫增强剂吸附不溶性金属离子
ES2681698T3 (es) 2011-03-02 2018-09-14 Glaxosmithkline Biologicals Sa Vacunas de combinación con menores dosis de antígeno y/o adyuvante
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
CA2866406A1 (en) 2012-03-08 2013-09-12 Novartis Ag Adjuvanted formulations of booster vaccines
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
JP2015525794A (ja) 2012-08-06 2015-09-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乳児においてrsv及び百日咳菌に対する免疫応答を惹起するための方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
MX362793B (es) 2013-03-08 2019-02-13 Janssen Vaccines & Prevention Bv Vacuna acelular contra pertussis.
JP6564367B2 (ja) 2013-08-05 2019-08-21 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 併用免疫原性組成物
CN114748616A (zh) * 2022-05-23 2022-07-15 中国医学科学院医学生物学研究所 一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) * 2023-01-10 2024-04-19 康希诺生物股份公司 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861417A0 (fi) 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
AP56A (en) 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.
EP1088830A3 (en) 1987-06-22 2004-04-07 Medeva Holdings B.V. Hepatitis b surface antigen particles
EP0299108B1 (en) 1987-07-17 1994-05-18 Rhein Biotech Gesellschaft für biotechnologische Prozesse und Produkte mbH DNA-molecules coding for FMDH control regions and structured gene for a protein having FMDH-activity and their uses
EP0414374B1 (en) 1989-07-25 1997-10-08 Smithkline Biologicals S.A. Novel antigens and methods for their preparation
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
ES2118963T3 (es) 1992-05-23 1998-10-01 Smithkline Beecham Biolog Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos.

Also Published As

Publication number Publication date
ATE222773T1 (de) 2002-09-15
EP0941117B1 (en) 2002-08-28
CZ295954B6 (cs) 2005-12-14
DE69733285T3 (de) 2010-03-25
EP0941117A1 (en) 1999-09-15
ES2240647T3 (es) 2005-10-16
PL188460B1 (pl) 2005-02-28
PL333127A1 (en) 1999-11-22
DE69715031T2 (de) 2003-05-08
JP2001503422A (ja) 2001-03-13
SI0941117T1 (en) 2002-12-31
HUP9904287A1 (hu) 2000-04-28
IL129530A (en) 2005-11-20
NZ335384A (en) 2000-10-27
NO2006005I1 (no) 2006-05-08
HK1050473B (zh) 2006-03-03
NO992156D0 (no) 1999-05-04
CZ164099A3 (cs) 1999-10-13
BRPI9712917B8 (pt) 2021-05-25
SA98181128B1 (ar) 2006-03-25
EP1240905B3 (en) 2009-08-26
ZA979984B (en) 1998-07-23
BR9712917A (pt) 1999-12-07
CN1130226C (zh) 2003-12-10
NO2006005I2 (no) 2010-04-12
AU5319698A (en) 1998-05-29
DE69733285D1 (de) 2005-06-16
IL129530A0 (en) 2000-02-29
BRPI9712917B1 (pt) 2019-12-03
WO1998019702A1 (en) 1998-05-14
CA2271008A1 (en) 1998-05-14
EP1240905B1 (en) 2005-05-11
DK1240905T3 (da) 2005-07-18
ATE295178T1 (de) 2005-05-15
CY2407B1 (en) 2004-09-10
PT1240905E (pt) 2005-09-30
KR100518044B1 (ko) 2005-09-30
DE69733285T2 (de) 2006-01-12
DE69715031D1 (de) 2002-10-02
CN1236321A (zh) 1999-11-24
HK1050473A1 (en) 2003-06-27
HUP9904287A3 (en) 2001-05-28
CY2568B1 (en) 2008-07-02
KR20000053092A (ko) 2000-08-25
NO992156L (no) 1999-05-04
DK1240905T5 (da) 2010-01-11
ES2240647T7 (es) 2010-03-31
DK0941117T3 (da) 2002-11-18
HK1022638A1 (en) 2000-08-18
GB9623233D0 (en) 1997-01-08
CA2271008C (en) 2008-07-22
CO4910171A1 (es) 2000-04-24
HU224126B1 (hu) 2005-05-30
PT941117E (pt) 2002-12-31
NO320186B1 (no) 2005-11-07
AR011509A1 (es) 2000-08-30
JP3980652B2 (ja) 2007-09-26
TR199900979T2 (xx) 1999-07-21
EP1240905A1 (en) 2002-09-18
TW471971B (en) 2002-01-11
LU91183I2 (fr) 2005-09-20
AU710475B2 (en) 1999-09-23
DE122005000046I1 (de) 2005-12-29
ES2182131T3 (es) 2003-03-01

Similar Documents

Publication Publication Date Title
CY2568B1 (en) Acellular pertussis vaccine with diphtheriae- and tetanus- toxoids
PL332633A1 (en) Vaccines
EP0958373A4 (en) Vaccines.
GB9616351D0 (en) Vaccine composition
GB9410922D0 (en) Vaccines
ZA9711565B (en) Vaccine
GB9625968D0 (en) Vaccine
ZA957482B (en) Vaccine
ZA973824B (en) Vaccines
ZA952806B (en) Vaccines
GB9419969D0 (en) Vaccine
AU715243C (en) Acellular antibordetella vaccine
GB9604595D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9606032D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9614182D0 (en) Vaccines
GB9602617D0 (en) Vaccines
GB9625967D0 (en) Vaccine
GB9625966D0 (en) Vaccine
GB9418057D0 (en) Vaccines
ZA956796B (en) Vaccines
GB9405925D0 (en) Vaccines
GB9418058D0 (en) Vaccines